Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in WGS — GeneDx Holdings Corp.

CIK 1446194 BALA CYNWYD, PA

Position in WGS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,502,143
+$2,985,124 QoQ
Shares Held
70,105
+501.0% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Mar 31, 2026
CallValue
$9,844,926
CallShares
153,300
PutValue
$8,008,234
PutShares
124,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $220,999,669 across 38 Diagnostics & Research names. WGS ranks #12 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WGS

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,844,926 153,300
2026-03-31 $4,502,143 70,105
2026-03-31 $8,008,234 124,700
2025-12-31 $1,517,019 11,664
2025-12-31 $44,259,418 340,300
2025-12-31 $49,578,872 381,200
2025-09-30 $38,732,530 359,500
2025-09-30 $13,417,724 124,538
2025-09-30 $51,984,550 482,500
2025-06-30 $73,358,757 794,700
2025-06-30 $2,299,072 24,906
2025-06-30 $52,875,168 572,800
2025-03-31 $2,246,804 25,369
2025-03-31 $8,900,782 100,500
2025-03-31 $21,822,416 246,400
2024-12-31 $7,294,014 94,900
2024-12-31 $3,981,348 51,800
2024-12-31 $473,150 6,156
2024-09-30 $573,449 13,512
2024-09-30 $2,779,820 65,500
2024-09-30 $1,158,612 27,300
2024-06-30 $1,155,388 44,200
2024-06-30 $554,168 21,200
2023-12-31 $550,275 200,100
2023-09-30 $777,504 213,600
2023-09-30 $95,732 26,300
2023-06-30 $163,900 27,500
2023-06-30 $1,502,516 252,100